Src tyrosine kinase signaling antagonizes nuclear localization of FOXO and inhibits its transcription factor activity
Margret H Bülow1, Torsten R Bülow2, Michael Hoch3
11] Institute of Molecular Systems Biology, Swiss Federal Institute of Technology (ETH) Zurich, 8093 Zurich, Switzerland [2] Life and Medical Sciences (LIMES) Institute, Program Unit Development and Genetics, Laboratory for Molecular Developmental Biology, University of Bonn, 53115 Bonn, Germany.
Abstract:
Biochemical experiments in mammalian cells have linked Src family kinase activity to the insulin signaling pathway. To explore the physiological link between Src and a central insulin pathway effector, we investigated the effect of different Src signaling levels on the Drosophila transcription factor dFOXO in vivo. Ectopic activation of Src42A in the starved larval fatbody was sufficient to drive dFOXO out of the nucleus. When Src signaling levels were lowered by means of loss-of-function mutations or pharmacological inhibition, dFOXO localization was shifted to the nucleus in growing animals, and transcription of the dFOXO target genes d4E-BP and dInR was induced. dFOXO loss-of-function mutations rescued the induction of dFOXO target gene expression and the body size reduction of Src42A mutant larvae, establishing dFOXO as a critical downstream effector of Src signaling. Furthermore, we provide evidence that the regulation of FOXO transcription factors by Src is evolutionarily conserved in mammalian cells.
Insights
Src signaling regulates insulin pathways by controlling the dFOXO transcription factor in fruit flies. Lowering Src activity moves dFOXO into the nucleus, impacting gene expression and growth.
Area of Science:
- Molecular Biology
- Cellular Signaling
- Genetics
Background:
- Src family kinases (SFKs) are implicated in mammalian insulin signaling.
- The precise in vivo physiological link between Src and insulin pathway effectors remains unclear.
Purpose of the Study:
- To investigate the in vivo physiological link between Src signaling and the insulin pathway effector dFOXO in Drosophila.
- To determine if dFOXO is a downstream effector of Src signaling.
Main Methods:
- Utilized Drosophila melanogaster as a model organism.
- Manipulated Src42A signaling levels through ectopic activation, loss-of-function mutations, and pharmacological inhibition.
- Assessed dFOXO nuclear localization via microscopy.
- Quantified the expression of dFOXO target genes (d4EBP, dInR) using RT-qPCR.
- Employed genetic epistasis analysis by introducing dFOXO loss-of-function mutations into Src42A mutants.
Main Results:
- Ectopic Src42A activation in larval fat bodies caused dFOXO nuclear exclusion.
- Reduced Src signaling (mutations or inhibition) led to nuclear dFOXO localization in growing larvae.
- Lowered Src signaling induced transcription of dFOXO target genes d4EBP and dInR.
- dFOXO loss-of-function rescued target gene induction and body size reduction in Src42A mutants.
- Evidence suggests conserved regulation of FOXO by Src in mammalian cells.
Conclusions:
- dFOXO is a critical downstream effector of Src signaling in vivo.
- Src signaling modulates dFOXO activity, influencing target gene expression and organismal growth.
- The regulatory relationship between Src and FOXO is evolutionarily conserved.
Related Concept Videos
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Receptor Tyrosine Kinases
TGF - β Signaling Pathway
Regulation of Nuclear Protein Sorting
The JAK-STAT Signaling Pathway
Co-activators and Co-repressors


